Equities

TruBridge Inc

  • Add to watchlist
  • Add to portfolio
  • Add an alert

TruBridge Inc

Actions
Health CareHealth Care Providers
  • Price (USD)19.50
  • Today's Change0.65 / 3.45%
  • Shares traded91.32k
  • 1 Year change-30.68%
  • Beta0.6341
Data delayed at least 15 minutes, as of Feb 13 2026 21:00 GMT.
More ▼
Notice
Important Notice
Please note that effective 5th February, 2026 the Financial Times will no longer publish or present securities from the Nairobi Stock Exchange.

Profile data is unavailable for this security.

About the company

TruBridge, Inc. is a provider of healthcare solutions and services for community hospitals, their clinics and other healthcare systems. The Company’s segments are Financial Health and Patient Care. The Financial Health reporting segment focuses on providing a complete revenue cycle management (RCM) solution for all care settings, regardless of their primary healthcare information solutions provider, along with business management, consulting, managed IT services, analytics, and business intelligence. The Patient Care segment provides comprehensive acute care solutions and related services for community hospitals and their physician clinics. The Patient Care segment also offers comprehensive patient engagement and empowerment technology solutions to improve patient outcomes and engagement strategies with care providers. Its HFMA Peer Reviewed suite of RCM offerings combines visibility and transparency to enhance productivity and support the financial health of healthcare organizations.

  • Revenue in USD (TTM)349.88m
  • Net income in USD5.42m
  • Incorporated2002
  • Employees3.20k
  • Location
    TruBridge Inc54 St. Emanuel StreetMOBILE 36602United StatesUSA
  • Phone+1 (251) 639-8100
  • Fax+1 (302) 636-5454
  • Websitehttps://trubridge.com/
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
CapsoVision Inc13.09m-22.56m226.25m----11.06--17.29-0.4873-0.48730.28260.4368----------------53.13---172.37--4.50--0.00--20.54---76.01------
908 Devices Inc57.64m-57.10m234.89m246.00--1.72--4.08-1.61-0.11161.623.770.31231.764.17234,296.80-30.94-18.01-37.82-19.6749.3552.89-99.07-78.453.12--0.00--18.7227.11-98.37--8.96--
Simulations Plus Inc78.68m-64.25m247.60m212.00--1.95--3.15-3.20-3.203.906.310.4701--4.28371,113.20-38.39-2.50-40.84-2.6559.6069.96-81.66-7.29----0.00--13.0913.74-750.17--7.57-24.21
Applied Energetics Inc1.15m-13.02m256.97m21.00------222.85-0.0599-0.05990.0053-0.00330.3065--7.7054,908.57-345.27-139.08-454.84-208.3658.5860.61-1,126.59-473.16---------7.78---24.71--51.42--
Quanterix Corp130.20m-95.66m268.12m471.00--0.8519--2.06-2.33-2.333.216.740.30451.444.06276,439.50-22.37-13.18-25.81-14.5351.5356.14-73.47-45.092.31--0.0029--12.3019.36-35.89---20.86--
Shoulder Innovations Inc41.63m-34.45m269.06m61.00--1.82--6.46-1.91-1.912.247.18----------------76.67---82.75--9.80--0.0913--64.07---50.85------
Sight Sciences Inc76.05m-46.11m283.39m216.00--4.37--3.73-0.8955-0.89551.471.230.58541.426.71352,092.60-35.49-35.50-39.37-38.5386.8382.63-60.63-94.208.93-76.380.384---1.4727.897.27---10.54--
Carlsmed Inc-100.00bn-100.00bn291.19m100.00--2.73----------4.01------------------------11.91--0.1265--97.16---31.49------
Trubridge Inc349.88m5.42m292.68m3.20k52.571.629.130.83650.37090.370924.2312.020.8737257.086.17109,338.401.39-0.91071.60-1.0353.1650.131.59-1.141.902.400.4768--0.9464.5256.05--61.10--
Owlet Inc99.64m-42.45m301.46m80.00------3.03-2.75-2.756.08-2.341.523.804.361,245,500.00-60.37-64.44-244.32-331.1152.0644.29-39.68-58.720.9074-2.48----44.529.4054.08---17.23--
Senseonics Holdings Inc29.30m-63.77m306.85m117.00--3.92--10.47-1.65-1.650.75651.920.2483.625.22250,410.30-53.98-71.11-70.98-94.7541.11-14.81-217.65-594.095.93-29.180.3109--0.36621.08-30.18--16.46--
Evolent Health Inc2.05bn-180.89m311.37m4.50k--0.3697--0.1516-1.57-1.5717.857.550.829--5.17456,456.00-5.17-5.93-6.41-8.0018.4221.07-6.24-7.16--0.1890.5572--30.0930.0434.31---6.87--
Delcath Systems Inc79.60m1.20m328.77m96.001,070.122.86235.854.130.00870.00872.103.251.021.267.70829,197.901.54-94.541.90-143.9786.2981.311.50-339.8513.71--0.00--1,701.7088.1044.66--87.69--
Rxsight Inc142.09m-35.73m330.58m498.00--1.20--2.33-0.8782-0.87823.506.720.45911.405.74285,313.30-11.54-19.50-12.45-21.5074.9857.17-25.15-52.0011.44--0.0004--57.09128.6143.52--5.89--
Data as of Feb 13 2026. Currency figures normalised to TruBridge Inc's reporting currency: US Dollar USD

Institutional shareholders

61.47%Per cent of shares held by top holders
HolderShares% Held
Pinetree Capital Ltd. (Investment Management)as of 12 Jan 20262.98m19.86%
Ocho Investments LLCas of 13 Mar 20251.12m7.45%
Strikwerda Investments BVas of 22 Sep 2025950.16k6.33%
Camac Partners LLCas of 31 Dec 2025861.64k5.74%
Nellore Capital Management LLCas of 01 Oct 2025789.47k5.26%
BlackRock Fund Advisorsas of 30 Sep 2025715.06k4.76%
The Vanguard Group, Inc.as of 31 Dec 2025661.45k4.41%
Dimensional Fund Advisors LPas of 30 Sep 2025434.59k2.90%
Martin & Co., Inc.as of 30 Sep 2025425.01k2.83%
Columbia Management Investment Advisers LLCas of 30 Sep 2025289.04k1.93%
More ▼
Data from 30 Jun 2025 - 28 Jan 2026Source: FactSet Research Systems Inc.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.